These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
620 related articles for article (PubMed ID: 15140615)
1. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD. Saiki S; Hirose G; Sakai K; Kataoka S; Hori A; Saiki M; Kaito M; Higashi K; Taki S; Kakeshita K; Fujino S; Miaki M J Neurol Sci; 2004 May; 220(1-2):105-11. PubMed ID: 15140615 [TBL] [Abstract][Full Text] [Related]
2. FP-CIT and MIBG scintigraphy in early Parkinson's disease. Spiegel J; Möllers MO; Jost WH; Fuss G; Samnick S; Dillmann U; Becker G; Kirsch CM Mov Disord; 2005 May; 20(5):552-61. PubMed ID: 15645531 [TBL] [Abstract][Full Text] [Related]
3. [Diagnostic value of cardiac 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy in Lewy body disorders]. Escamilla-Sevilla F; Pérez-Navarro MJ; Muñoz-Pasadas M; Ortega-Léon T; Gallego-Peinado M; Cabello-García D; Gómez Río M; Ortega-Moreno A; Carnero-Pardo C; Rebollo-Aguirre AC; Mínguez-Castellanos A Neurologia; 2009 Apr; 24(3):170-6. PubMed ID: 19418293 [TBL] [Abstract][Full Text] [Related]
5. Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies. Kashihara K; Ohno M; Kawada S; Okumura Y J Nucl Med; 2006 Jul; 47(7):1099-101. PubMed ID: 16818943 [TBL] [Abstract][Full Text] [Related]
6. Retrospective analysis of parkinsonian patients exhibiting normal (123)I-MIBG cardiac uptake. Mizutani Y; Ito S; Murate K; Hirota S; Fukui T; Hikichi C; Ishikawa T; Shima S; Ueda A; Kizawa M; Asakura K; Mutoh T J Neurol Sci; 2015 Dec; 359(1-2):236-40. PubMed ID: 26671120 [TBL] [Abstract][Full Text] [Related]
7. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease. Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056 [TBL] [Abstract][Full Text] [Related]
8. Differentiating Parkinson's disease from multiple system atrophy by [123I] meta-iodobenzylguanidine myocardial scintigraphy and olfactory test. Kikuchi A; Baba T; Hasegawa T; Sugeno N; Konno M; Takeda A Parkinsonism Relat Disord; 2011 Nov; 17(9):698-700. PubMed ID: 21840242 [TBL] [Abstract][Full Text] [Related]
9. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy]. Yoshita M; Hayashi M; Hirai S Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173 [TBL] [Abstract][Full Text] [Related]
10. [Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver]. Oka H; Yoshioka M; Morita M; Mochio S; Inoue K Rinsho Shinkeigaku; 2003 Aug; 43(8):465-9. PubMed ID: 14658397 [TBL] [Abstract][Full Text] [Related]
11. Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study. Burn DJ; Rowan EN; Minett T; Sanders J; Myint P; Richardson J; Thomas A; Newby J; Reid J; O'Brien JT; McKeith IG Mov Disord; 2003 Aug; 18(8):884-9. PubMed ID: 12889077 [TBL] [Abstract][Full Text] [Related]
12. Cardiac ¹²³I-MIBG scintigraphy as an outcome-predicting tool for subthalamic nucleus stimulation in Parkinson's disease. Yamada K; Shiraishi SY; Hamasaki T; Kuratsu J Acta Neurochir (Wien); 2010 Dec; 152(12):2063-8. PubMed ID: 20927559 [TBL] [Abstract][Full Text] [Related]
13. Yang T; Wang L; Li Y; Cheng M; Jiao J; Wang Q; Guo H J Neurol Sci; 2017 Feb; 373():48-51. PubMed ID: 28131225 [TBL] [Abstract][Full Text] [Related]
14. Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease. Kitayama M; Wada-Isoe K; Irizawa Y; Nakashima K J Neurol Sci; 2008 Jan; 264(1-2):22-6. PubMed ID: 17706675 [TBL] [Abstract][Full Text] [Related]
15. The clinically important difference on the unified Parkinson's disease rating scale. Shulman LM; Gruber-Baldini AL; Anderson KE; Fishman PS; Reich SG; Weiner WJ Arch Neurol; 2010 Jan; 67(1):64-70. PubMed ID: 20065131 [TBL] [Abstract][Full Text] [Related]
16. Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphy. Köllensperger M; Seppi K; Liener C; Boesch S; Heute D; Mair KJ; Mueller J; Sawires M; Scherfler C; Schocke MF; Donnemilier E; Virgolini I; Wenning GK; Poewe W Mov Disord; 2007 Sep; 22(12):1771-6. PubMed ID: 17579357 [TBL] [Abstract][Full Text] [Related]
17. Diagnosing Parkinson's disease using videotaped neurological examinations: validity and factors that contribute to incorrect diagnoses. Louis ED; Levy G; Côte LJ; Mejia H; Fahn S; Marder K Mov Disord; 2002 May; 17(3):513-7. PubMed ID: 12112199 [TBL] [Abstract][Full Text] [Related]
18. Application of the International Cooperative Ataxia Scale rating in multiple system atrophy. Tison F; Yekhlef F; Balestre E; Chrysostome V; Quinn N; Wenning GK; Poewe W Mov Disord; 2002 Nov; 17(6):1248-54. PubMed ID: 12465064 [TBL] [Abstract][Full Text] [Related]
19. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Orimo S; Amino T; Itoh Y; Takahashi A; Kojo T; Uchihara T; Tsuchiya K; Mori F; Wakabayashi K; Takahashi H Acta Neuropathol; 2005 Jun; 109(6):583-8. PubMed ID: 15933869 [TBL] [Abstract][Full Text] [Related]